Raspberry Pi’s 2025 Beat Priced In—DRAM Squeeze Could Test 2026 Growth

The core event is clear. Raspberry Pi Holdings delivered a strong 2025 performance, with adjusted EBITDA of at least $45 million. That figure represents a 20% year-over-year increase and exceeded analyst expectations by approximately 10%. The market reacted decisively, sending the stock up 21.8% on the news. This surge, which pushed the share price to GBX 353.31, is the classic reaction to a beat.

The central question now is whether the good news is already priced in. The stock's valuation, trading at a premium P/E ratio, now implies a smooth path forward. This sets up a vulnerability. The company itself has flagged a primary risk for 2026: severe and constrained supply of LPDDR4 memory, driven by AI data center demand. As the company noted, "some major suppliers now indicating limitations of supply at high densities" and "DRAM, especially LPDDR4, is getting harder to source and more expensive." This isn't just a minor cost headwind; it's a fundamental supply constraint that could pressure margins and limit growth if not managed.

The immediate reaction to the 2025 beat has been to look past this uncertainty. The stock's 20% pop suggests the market is focusing on the proven execution and the robust demand continuing into the first half of 2026. However, the company's own guidance for the second half of 2026 is one of limited visibility due to uncertain DRAM availability. This creates an expectations gap. The current price may not fully reflect the risk that the supply chain squeeze could intensify, forcing difficult trade-offs between growth and profitability in the latter half of the year.

Valuation and the "Priced for Perfection" Trap

The market's reaction to the 2025 beat has been to look past the 2026 uncertainty. The stock's 21.8% pop suggests investors are focusing on the proven execution and the robust demand continuing into the first half of 2026. However, the company's own guidance for the second half of 2026 is one of limited visibility due to uncertain DRAM availability. This creates an expectations gap. The current price may not fully reflect the risk that the supply chain squeeze could intensify, forcing difficult trade-offs between growth and profitability in the latter half of the year.

The valuation tells a clearer story. The stock now trades at a trailing P/E ratio of 97.40. That is a significant multiple, pricing in substantial future growth. Compare that to the company's own history: the P/E was 128 at the end of 2024. The massive re-rating on the 2025 beat has compressed the multiple, but it remains a premium valuation. This suggests the market is willing to pay up for the growth trajectory, even as the path becomes cloudier.

The critical point is what is already priced in. The current price implies a smooth path forward, with the 2025 beat serving as a powerful validation of the growth story. Yet the company itself has flagged a primary risk for 2026: severe and constrained supply of LPDDR4 memory, driven by AI data center demand. As the company noted, "some major suppliers now indicating limitations of supply at high densities" and "DRAM, especially LPDDR4, is getting harder to source and more expensive." This isn't just a minor cost headwind; it's a fundamental supply constraint that could pressure margins and limit growth if not managed.

The market's focus on the 2025 beat may have overshadowed this persistent 2026 uncertainty. The stock's premium valuation now leaves little room for error. If the supply chain squeeze intensifies in the second half of 2026, forcing price increases or production cuts, the expectations gap could widen quickly. The "priced for perfection" trap is set. The current price already reflects the good news of 2025 and the confidence in a strong first half of 2026. The risk is that the bad news for the second half is not yet fully reflected.

Catalysts, Risks, and What to Watch

The setup for the next few months is clear. The stock's premium valuation and the company's own guidance create a binary near-term test. The key catalyst is the H1 2026 trading update, which will confirm or break management's claim that a sufficient supply of memory across most LPDDR4-dependent products to meet expected H1 2026 demand is secured. A strong update showing growth and maintained profitability would validate the current thesis and the "priced for perfection" view for the first half. Any hint of supply strain or margin pressure would quickly challenge that narrative.

The primary risk remains the deterioration of the memory supply situation. The company has been proactive, raising board prices and developing product variants to manage the squeeze. But if the supply chain tightens further in the second half, forcing price increases, shipment delays, or costly redesigns, the high-margin valuation will come under severe pressure. The market's focus on the 2025 beat has likely overshadowed this persistent 2026 uncertainty. The stock's beta of 1.90 indicates it is nearly twice as volatile as the broader market, meaning it will amplify any news on this front.

Investors should watch for two specific signals as 2026 unfolds. First, monitor any shift in the consensus rating from the current "Hold" rating. A downgrade would signal growing concern over the supply chain risk. Second, track the company's ability to maintain its prudent cash management and its year-end net cash position of $28 million. A strong balance sheet provides a buffer, but if cash flow is diverted to manage inventory or absorb costs, it could limit strategic flexibility.

The bottom line is that the stock's recent rally has priced in a smooth first half. The real test begins in the second half of the year. For now, the path is defined by a single, critical question: does the company's inventory buffer hold through June? Any sign it doesn't will force a reassessment of the entire growth story.